Evidence map›Paper›PMID 42216827›Full record

ArticleAmerican journal of hematology2026

Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T-Cell Lymphoma.

Shenrui Bai, Yongping Song, Liang Wang, Fang Liu, Yexiong Li, Shunan Qi, Zhigang Peng, Ying Zhao, Huiqiang Huang, Yi Xia and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Shenrui BaiState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yongping SongDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Liang WangDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China.ORCID https://orcid.org/0000-0001-6140-914X
Fang LiuState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yexiong LiDepartment of Radiation Oncology, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Shunan QiDepartment of Radiation Oncology, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Zhigang PengDepartment of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
Ying ZhaoDepartment of Hematology, The First People's Hospital of Foshan, Foshan, People's Republic of China.
Huiqiang HuangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yi XiaState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Bing BaiState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Xiaojie FangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Man NieState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Jun CaiState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yi CaoState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Xinna GaoState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Qihua ZouState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Qingqing CaiState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Yuchen ZhangState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.ORCID https://orcid.org/0000-0003-3378-1520

Funding

China National Postdoctoral Program for Innovative Talents BX20240445Clinical Oncology Foundation of Chinese Society of Clinical Oncology Y-2024AZ(BTK)ZD-0105Clinical Oncology Foundation of Chinese Society of Clinical Oncology Y-SY2021ZD-0110Guangzhou Municipal Science and Technology Program key projects 2024B03J1291National Natural Science Foundation of China 82230001National Natural Science Foundation of China 82270199National Natural Science Foundation of China 82500234Noncommunicable Chronic Diseases-National Science and Technology Major Project 2025ZD0544300Sun Yat-Sen University Clinical Research 5010 Program 2020009
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical outcomesimmunotherapynatural killer/T‐cell lymphomaprognostic factors

Identifiers

PMID42216827
PMCPMC13544475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.